American National Red Cross   Report issue

Foundation Phase 2
Founded: Washington D.C. United States (1881)

Organization Overview

First Clinical Trial
1999
NCT00001999
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

sodium ferric gluconate complex (2 trials)

Drugs in Other Trials (3)

ganciclovir (cytovene) (1 trial)

immune globulin (human) (1 trial)

intercept platelets (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4